Author

Hajime Okada

Tel Aviv UniversityPrimary ORCID profile (0000-0002-3204-3633 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Hajime OkadaiD3 papers · National Institute of Genetics

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Eran SdeoriD· 1 shared Gil LeoriD· 1 shared Guy Wolf· 1 shared Kathrin LaueiD· 1 shared Ron Saad· 1 shared Shlomit Strulov ShachariD· 1 shared Tom WinkleriD· 1 shared Uri Ben‐DavidiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Eran SdeorORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Chromosome-arm 17p Loss Renders Breast Cancer Cells Vulnerable to AURKB Inhibition

Tom Winkler, Eran Sdeor, Ron Saad, Hajime Okada, Kathrin Laue, Gil Leor, Guy Wolf, Shlomit Strulov Shachar, Uri Ben‐David

This study identifies Del17p as a biomarker for AURKB inhibition in breast cancer, showing increased sensitivity to AURKB inhibitors in Del17p tumors.

bioRxiv · Dec 2, 2025 · PreprintCancer Biology